Table 2. Significantly enriched annotations regulated by miR-218 in SAS.
Number of Genes | p Value | Annotations |
---|---|---|
21 | 2.05E-04 | Pathways in cancer |
17 | 1.45E-04 | Focal adhesion |
15 | 4.58E-04 | Endocytosis |
14 | 2.79E-03 | Regulation of actin cytoskeleton |
13 | 8.44E-04 | Protein processing in endoplasmic reticulum |
11 | 1.14E-04 | ECM-receptor interaction |
10 | 4.30E-03 | Lysosome |
10 | 4.37E-02 | Chemokine signaling pathway |
9 | 4.89E-03 | Amoebiasis |
8 | 1.22E-04 | Bladder cancer |
8 | 2.53E-03 | Pancreatic cancer |
8 | 6.78E-03 | Apoptosis |
8 | 3.94E-02 | Glutamatergic synapse |
8 | 4.36E-02 | Tight junction |
7 | 7.05E-03 | Adipocytokine signaling pathway |
7 | 2.18E-02 | Small cell lung cancer |
6 | 7.05E-03 | Lysine degradation |
6 | 8.15E-03 | Mineral absorption |
6 | 2.82E-02 | p53 signaling pathway |
6 | 3.33E-02 | PPAR signaling pathway |
6 | 3.38E-02 | Adherens junction |
5 | 3.95E-02 | Non-small cell lung cancer |
5 | 3.95E-02 | Vibrio cholerae infection |
4 | 2.18E-02 | beta-Alanine metabolism |